ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » 6W020: Miscellaneous Rheumatic & Inflammatory Disease III: Novel Therapies (2900–2905)

Date: Wednesday, November 13, 2019

Time: 11:00AM-12:30PM

Meeting: 2019 ACR/ARP Annual Meeting

Abstract Number: 2900
Interferon Signature Predicts Response to Tofacitinib in Haploinsufficiency of A20
Abstract Number: 2901
Anakinra Treatment in Patients with Familial Mediterranean Fever: A Single-center Experience
Abstract Number: 2902
The Use and Safety of Rituximab in Connective Tissue Disease Associated Interstitial Lung Disease
Abstract Number: 2903
Cryopyrin-Associated Periodic Syndrome Treated with Canakinumab – Long-Term Follow-up Data Documents Sustained Safety and Remission
Abstract Number: 2904
Rituximab as Rescue Therapy in Treatment-Refractory CTD-ILD
Abstract Number: 2905
Rilonacept in Recurrent Pericarditis: Efficacy and Safety Data from an Ongoing Phase 2 Pilot Clinical Trial

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences